The Patent Finder

Terms ending in 2033

Kymab Limited

Every in-force patent on Kymab Limited's record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,788,534Animal Models and Therapeutic Molecules
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 10,226,033Animal Models and Therapeutic Molecules
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 10,730,930Antibodies, Variable Domains & Chains Tailored for Human Use
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 11,820,810Antibodies, Variable Domains and Chains Tailored for Human Use
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 8,883,157Targeting Rare Human PCSK9 Variants for Cholesterol Treatment
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 8,951,523Targeting Rare Human PCSK9 Variants for Cholesterol Treatment
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 8,999,341Targeting Rare Human PCSK9 Variants for Cholesterol Treatment
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 9,034,331Targeting Rare Human PCSK9 Variants for Cholesterol Treatment
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 9,034,332Precision Medicine by Targeting Rare Human PCSK9 Variants for Cholesterol Treatment
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
US 9,040,052Precision Medicine By Targeting Rare Human PCSK9 Variants for Cholesterol Treatment
In force
 · High confidence
Kymab LimitedIn forceHigh confidence
7 more term ends in 2033 · Pro
10 of 17 patents shown. Soonest term end first, then patent number.
Pro members see all 17.
Upgrade to Pro
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited